KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) Revenue (2016 - 2025)

Thermo Fisher Scientific's Revenue history spans 17 years, with the latest figure at $12.2 billion for Q4 2025.

  • For the quarter ending Q4 2025, Revenue rose 7.2% year-over-year to $12.2 billion, compared with a TTM value of $44.6 billion through Dec 2025, up 3.91%, and an annual FY2025 reading of $44.6 billion, up 3.91% over the prior year.
  • Revenue for Q4 2025 was $12.2 billion at Thermo Fisher Scientific, up from $11.1 billion in the prior quarter.
  • The five-year high for Revenue was $12.2 billion in Q4 2025, with the low at $9.3 billion in Q3 2021.
  • Average Revenue over 5 years is $10.7 billion, with a median of $10.7 billion recorded in 2021.
  • Year-over-year, Revenue skyrocketed 59.0% in 2021 and then decreased 9.38% in 2023.
  • Tracing TMO's Revenue over 5 years: stood at $10.7 billion in 2021, then increased by 6.99% to $11.5 billion in 2022, then dropped by 4.93% to $10.9 billion in 2023, then increased by 4.68% to $11.4 billion in 2024, then grew by 7.2% to $12.2 billion in 2025.
  • Per Business Quant, the three most recent readings for TMO's Revenue are $12.2 billion (Q4 2025), $11.1 billion (Q3 2025), and $10.9 billion (Q2 2025).